Sophie DOMINGUES

Mrs. Sophie DOMINGUES

I-Stem, Paris, Île-de-France, France
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2017 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
KMkarim ben m'barek
karim ben m'barek
WHWalter Habeler
Walter Habeler
APAlexandra Plancheron
Alexandra Plancheron
MJMohamed Jarraya
Mohamed Jarraya
FRFlorian Regent
Florian Regent
CMChristelle Monville
Christelle Monville
Human ESC–derived retinal pigment epithelial cell sheets are more effective than cell suspensions at rescuing photoreceptor cell loss in rats with retinal dystrophy.

27 January 2021 in Cells
Verified
Journal Article
Open access
PDF file
MJMargot Jarrige
Margot Jarrige
EFElie FRANK
Elie FRANK
EHElise Herardot
Elise Herardot
SMSabrina Martineau
Sabrina Martineau
ADAnnabelle Darle
Annabelle Darle
KMkarim ben m'barek
karim ben m'barek
The rapid progress in the field of stem cell research has laid strong foundations for their use in regenerative medicine applications of injured or diseased tissues. Growing evidences indicate that some observed therapeutic outcomes of stem cell-based therapy are due to paracrine effects rather than long-term engraftment and survival of transplanted cells. Given their ability to cross biological barriers and mediate intercellular information transfer of bioactive molecules, extracellular vesicles are being explored as potential cell-free therapeutic agents. In this review, we first discuss the state of the art of regenerative medicine and its current limitations and challenges, with particular attention on pluripotent stem cell-derived products to repair organs like the eye, heart, skeletal muscle and skin. We then focus on emerging beneficial roles of extracellular vesicles to alleviate these pathological conditions and address hurdles and operational issues of this acellular strategy. Finally, we discuss future directions and examine how careful integration of different approaches presented in this review could help to potentiate therapeutic results in preclinical models and their good manufacturing practice (GMP) implementation for future clinical trials.

29 March 2022 in Cells
Verified
Journal Article
Open access
PDF file
SDSophie DOMINGUES
Sophie DOMINGUES
ADAnnabelle Darle
Annabelle Darle
YMYolande Masson
Yolande Masson
MSManoubia Saidani
Manoubia Saidani
ELEmilie Lagoutte
Emilie Lagoutte
CBChristine Baldeschi
Christine Baldeschi
Chronic wounds, such as leg ulcers associated with sickle cell disease, occur as a consequence of a prolonged inflammatory phase during the healing process. They are extremely hard to heal and persist as a significant health care problem due to the absence of effective treatment and the uprising number of patients. Indeed, there is a critical need to develop novel cell- and tissue-based therapies to treat these chronic wounds. Development in skin engineering leads to a small catalogue of available substitutes manufactured in Good Manufacturing Practices compliant (GMPc) conditions. Those substitutes are produced using primary cells that could limit their use due to restricted sourcing. Here, we propose GMPc protocols to produce functional populations of keratinocytes and fibroblasts derived from pluripotent stem cells to reconstruct the associated dermo-epidermal substitute with plasma-based fibrin matrix. In addition, this manufactured composite skin is biologically active and enhances in vitro wounding of keratinocytes. The proposed composite skin opens new perspectives for skin replacement using allogeneic substitute.

28 April 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
JCJulien Coutier
Julien Coutier
MBManon Bonnette
Manon Bonnette
SMSabrina Martineau
Sabrina Martineau
AMAurélie Mercadier
Aurélie Mercadier
SDSophie DOMINGUES
Sophie DOMINGUES
CBChristine Baldeschi
Christine Baldeschi

19 December 2017 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
SDSophie DOMINGUES
Sophie DOMINGUES
YMYolande Masson
Yolande Masson
AMAurore Marteyn
Aurore Marteyn
JAJennifer Allouche
Jennifer Allouche
APAnselme L. Perrier
Anselme L. Perrier
Gilles LemaîtreGilles Lemaître
Gilles Lemaître
Epidermal grafting using cells derived from pluripotent stem cells will change the face of this side of regenerative cutaneous medicine. To date, the safety of the graft would be the major unmet deal in order to implement long-term skin grafting. In this context, experiments on large animals appear unavoidable to assess this question and possible rejection. Cellular tools for large animal models should be constructed. In this study, we generated monkey pluripotent stem cell-derived keratinocytes and evaluated their capacities to reconstruct an epidermis, in vitro as well as in vivo. Monkey pluripotent stem cells were differentiated efficiently into keratinocytes able to reconstruct fully epidermis presenting a low level of major histocompatibility complex class-I antigens, opening the way for autologous or allogeneic epidermal long-term grafting. Functional keratinocytes generated from nonhuman primate embryonic stem cells and induced pluripotent stem cells reproduce an in-vitro and in-vivo stratified epidermis. These monkey skin grafts will be considered to model autologous or allogeneic epidermal grafting using either embryonic stem cells or induced pluripotent stem cells. This graft model will allow us to further investigate the safety, efficacy and immunogenicity of nonhuman primate PSC-derived epidermis in the perspective of human skin cell therapy.

7 September 2022
Verified
Conference Paper
Closed access
SDSophie DOMINGUES
Sophie DOMINGUES
ADAnnabelle Darle
Annabelle Darle
YMYolande Masson
Yolande Masson
MSManoubia Saidani
Manoubia Saidani
ELEmilie Lagoutte
Emilie Lagoutte
CBChristine Baldeschi
Christine Baldeschi
Chronic wounds, such as leg ulcers associated with sickle cell disease, occur as consequence of a prolonged inflammatory phase during the healing | POSTER